BioStratum

BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic nephropathy, and preclinical compounds for the treatment of diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.